Introduction: A Comprehensive Approach to Kidney Health
Kidney health is a fundamental aspect of overall bodily well-being. The kidneys perform many vital functions, including blood filtration, blood pressure regulation, hormone production, and the maintenance of electrolyte and mineral balance. Impairments in kidney function can lead to the development of serious diseases such as chronic kidney disease (CKD) and related complications, including mineral metabolism disorders and, in some cases, stone formation.
Although the presented scientific publications thoroughly cover aspects of chronic kidney disease and mineral and bone disorders, they do not contain specific information on the direct treatment of urolithiasis. Nevertheless, understanding the relationship between these conditions is extremely important for a comprehensive approach to maintaining kidney health and preventing various pathologies.
Chronic Kidney Disease (CKD): Overview and Management
Chronic kidney disease (CKD) is a serious condition affecting a significant portion of the adult population worldwide. It is estimated that CKD affects about 14% of adults in the US and at least 10% of the global population [8]. This condition is characterized by a gradual loss of kidney function, which can lead to multiple complications.
Key measures for primary prevention and adequate management of CKD are strict control of blood glucose levels and blood pressure [8]. These factors play a decisive role in slowing the progression of the disease. Modern approaches to the assessment and treatment of CKD are constantly updated, including new methods for measuring the glomerular filtration rate (GFR), such as CKD-EPI 2021 using cystatin C, as well as Kidney Disease Improving Global Outcomes (KDIGO) guidelines [8].
Recent changes in CKD therapy include the introduction of new disease-modifying drugs and agents for managing complications such as CKD-related anemia. These include a novel mineralocorticoid receptor antagonist and a hypoxia-inducible factor prolyl hydroxylase inhibitor [8]. These advances emphasize the importance of continuous knowledge updating and a personalized approach to managing CKD patients.
Mineral and Bone Disorders in CKD (CKD-MBD): The Key to Understanding
One of the most significant and complex complications of chronic kidney disease is mineral and bone disorders, known as CKD-MBD. In 2017, KDIGO published updated clinical guidelines for the diagnosis, evaluation, prevention, and treatment of CKD-MBD. Since then, new data have emerged regarding the assessment of mineral metabolism disorders, bone quality and turnover, the detection and inhibition of vascular calcification, target vitamin D levels, and parathyroid hormone regulation [5].
In October 2023, KDIGO held a Controversies Conference dedicated to CKD-MBD to review new data and identify knowledge gaps for personalized treatment. Participants concluded that the 2017 guidelines largely align with available evidence. However, the structure of the 2017 guideline, consisting of three main sections—biochemical abnormalities of mineral metabolism, bone disorders, and vascular calcification—may no longer fully reflect current evidence [5].
Understanding CKD-MBD involves a comprehensive study of the following aspects:
- Mineral Metabolism Disorders: Imbalances of calcium, phosphorus, and other minerals.
- Bone Quality and Turnover: Changes in bone structure and metabolism leading to osteodystrophy.
- Vascular Calcification: Deposition of calcium in blood vessel walls, which is a major cardiovascular risk.
- Vitamin D and Parathyroid Hormone Levels: These hormones play a central role in regulating calcium-phosphorus metabolism, and their imbalance is frequently observed in CKD [5].
The Link Between CKD, Mineral Balance, and Urolithiasis
Although the presented scientific sources [5, 8] do not focus directly on kidney stone treatment, they provide critically important information on conditions closely related to the development of urolithiasis. Mineral metabolism disorders, detailed in the context of CKD-MBD [5], are among the primary risk factors for kidney stone formation.
For example, imbalances of calcium, phosphorus, oxalates, and uric acid in the urine, as well as changes in vitamin D and parathyroid hormone levels, can promote the crystallization of these substances and the formation of kidney stones. CKD patients often face such disorders, making them more vulnerable to developing urolithiasis. Thus, comprehensive management of CKD and CKD-MBD, including monitoring and correcting mineral metabolism, is an important component of preventing new stone formation and recurrences in patients with comorbid kidney diseases.
Understanding the mechanisms underlying CKD and CKD-MBD enables physicians to develop more effective strategies to maintain overall kidney health and reduce the risk of various complications, including urolithiasis. A personalized approach based on thorough diagnosis and assessment of individual risk factors is key to successfully managing these complex conditions [5].
The Importance of Diagnostics and a Personalized Approach
Modern medicine is increasingly moving toward a personalized approach to treatment. In the context of CKD and CKD-MBD, this means taking into account individual patient characteristics, disease severity, localization, and response to prior treatment [4, 5]. KDIGO recommendations emphasize the importance of ongoing monitoring and adaptation of therapeutic strategies [5, 8].
For patients with CKD and mineral metabolism disorders, regular assessment of kidney function, blood and urine mineral levels, and bone tissue status is extremely important. This allows for the timely detection of abnormalities and adjustment of treatment, preventing further disease progression and the development of complications that may contribute to kidney stone formation.
Conclusion: Prevention and Kidney Health Management
Chronic kidney disease and associated mineral and bone disorders pose serious health challenges. Although the presented sources do not contain direct recommendations for urolithiasis treatment, they emphasize the critical role of CKD control and mineral balance in the body. Effective management of these conditions, based on the latest scientific evidence and KDIGO guidelines, can significantly improve patients' quality of life and reduce the risk of various complications, including kidney stone formation.
Understanding the complex interactions between kidney function, mineral metabolism, and overall health status is the basis for developing comprehensive prevention and treatment strategies. For patients with any kidney diseases, it is crucial to work closely with their attending physician to develop an individualized management plan that takes into account all aspects of their condition.
References
- 1. Current treatment of ulcerative colitis. (World journal of gastroenterology, 2011) https://pubmed.ncbi.nlm.nih.gov/21912469/
- 2. AGA Technical Review on the Management of Mild-to-Moderate Ulcerative Colitis. (Gastroenterology, 2019) https://pubmed.ncbi.nlm.nih.gov/30576642/
- 3. A case of type B lactic acidosis as a complication of chronic myelomonocytic leukaemia: a case report and review of the literature. (Journal of medical case reports, 2015) https://pubmed.ncbi.nlm.nih.gov/25588681/
- 4. Ulcerative Colitis: Shifting Sands. (Drugs in R&D, 2019) https://pubmed.ncbi.nlm.nih.gov/30827006/
- 5. Chronic kidney disease-mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. (Kidney international, 2025) https://pubmed.ncbi.nlm.nih.gov/39864017/
- 6. Real-world evidence of galcanezumab for migraine treatment in Japan: a retrospective analysis. (BMC neurology, 2022) https://pubmed.ncbi.nlm.nih.gov/36585619/
- 7. Management of chronic hand and foot eczema. An Australia/New Zealand Clinical narrative. (The Australasian journal of dermatology, 2021) https://pubmed.ncbi.nlm.nih.gov/32776537/
- 8. Updates in Chronic Kidney Disease. (Journal of pharmacy practice, 2024) https://pubmed.ncbi.nlm.nih.gov/38877746/
Disclaimer: The information provided in this article is for reference purposes only and cannot serve as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified physician regarding any questions concerning your health or medical condition.